secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001140361-24-030638
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys receives CE Mark for four women's health products, enters EU market
---------------------------------------------------------------------------

- Received EU MDR certificate and CE Mark for FemaSeed, FemVue, FemCerv, FemCath.
- Approvals allow Femasys to begin marketing all four products in the European Union.
- CEO Kathy Lee-Sepsick: CE Mark validates commitment to highest quality and safety standards.
- Company will identify strategic distribution partners to commercialize products throughout the EU.
- Initial US commercial team build-out completed; EU expansion follows CE Mark approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124030638/0001140361-24-030638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124030638/ef20031386_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-030638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer